NCT00589667 2014-04-02A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)Memorial Sloan Kettering Cancer CenterPhase 2 Completed26 enrolled 8 charts